Three Dana-Farber Cancer Institute faculty members elected to the National Academy of Medicine

Posted date

K. Vish Viswanath, PhD, Kimberly Stegmaier, MD and Kathleen H. Burns, MD, PhD of Dana-Farber Cancer Institute have been elected to the National Academy of Medicine. Election to the Academy is considered one of the highest honors in the fields of health and medicine and recognizes individuals who have demonstrated outstanding professional achievement and commitment to service.

“I am thrilled to welcome these outstanding health and medicine leaders into the National Academy of Medicine,” said NAM President Monica M. Bertagnolli. “Their extraordinary talent and commitment to advancing evidence-based guidance and solutions for our country’s greatest health care challenges will strengthen our efforts to improve health for all.”

K. Vish Viswanath, PhD serves as Lee Kum Kee Professor of Health Communication in the Department of Social and Behavioral Sciences at the Harvard T. H. Chan School of Public Health and in the McGraw-Patterson Center for Population Sciences at the Dana-Farber Cancer Institute. In being elected to the Academy, Viswanatha was honored for his work on translational communication science and health inequities that have profoundly influenced scholarship and practice of public health, and that has been widely used by local, national, and international bodies. Viswanath’s lab seeks to influence public health policy and practice through knowledge translation and translational communication. Most recently, Viswanath led a panel of scientific investigators gathered by the National Academies of Sciences, Engineering, and Medicine that produced a seminal report on defining misinformation in science and laying out strategies for mitigating its spread and potential harms.   

Kimberly Stegmaier, MD, is Chair of the Department of Pediatric Oncology at Dana-Farber and associate chief, Division of Hematology/Oncology, Boston Children’s Hospital. She was recognized by the Academy for developing highly innovative methods for genetic and chemical genomic screens of cell phenotypes. Stegmaier applied these successfully to understand pediatric cancer biology and discover drugs to treat specific cancers. This work prompted multiple drug discovery efforts in academia and industry and provides insight into oncogenic mechanisms underlying cancer.

Kathleen H. Burns, MD, PhD serves as chair of the Department of Pathology at Dana-Farber and was recognized for her pioneering work on transposable elements in human disease. Burn’s discoveries have highlighted long interspersed nuclear element-1 (LINE-1) activity as a source of heritable genetic variation and a hallmark of cancers. Her laboratory is establishing foundational concepts for LINE-1 contributions to cancer pathogenesis and ways to exploit this biology for diagnostic and therapeutic opportunity.

New members to NAM are elected by current members through a process that recognizes individuals who have made major contributions to the advancement of the medical sciences, health care, and public health. A diversity of talent among NAM’s membership is assured by its Articles of Organization, which stipulate that at least one-quarter of the membership is selected from fields outside the health professions — for example, from such fields as law, engineering, social sciences, and the humanities.

Established originally as the Institute of Medicine in 1970 by the National Academy of Sciences, the National Academy of Medicine addresses critical issues in health, science, medicine, and related policy and inspires positive actions across sectors. NAM works alongside the National Academy of Sciences and National Academy of Engineering to provide independent, objective analysis and advice to the nation and conduct other activities to solve complex problems and inform public policy decisions. 
 


News Category
Research
Awards

Media Contacts

If you are a journalist and have a question about this story, please call 617-632-4090 and ask to speak to a member of the media team, or email media@dfci.harvard.edu.

The Media Team cannot respond to patient inquiries. For more information, please see Contact Us.

k-vish-viswanath566x487.jpg

K. "Vish" Viswanath, PhD

kimberly-stegmaier-566x487.jpg

Kimberly Stegmaier, MD

kathleen-burns566x487.jpg

Kathleen Burns, MD, PhD